OMERS Administration Corp’s Envoy Medical Warrant COCHW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.55K Hold
23,333
﹤0.01% 1084
2025
Q4
$1.01K Hold
23,333
﹤0.01% 1016
2025
Q3
$877 Hold
23,333
﹤0.01% 1125
2025
Q2
$1.13K Hold
23,333
﹤0.01% 850
2025
Q1
$770 Hold
23,333
﹤0.01% 1018
2024
Q4
$1.14K Hold
23,333
﹤0.01% 946
2024
Q3
$1.85K Hold
23,333
﹤0.01% 857
2024
Q2
$1.38K Hold
23,333
﹤0.01% 1003
2024
Q1
$2.45K Hold
23,333
﹤0.01% 413
2023
Q4
$467 Hold
23,333
﹤0.01% 286
2023
Q3
$1.98K Hold
23,333
﹤0.01% 189
2023
Q2
$1.07K Hold
23,333
﹤0.01% 204
2023
Q1
$821 Hold
23,333
﹤0.01% 283
2022
Q4
$887 Hold
23,333
﹤0.01% 308
2022
Q3
$1K Hold
23,333
﹤0.01% 347
2022
Q2
$3K Hold
23,333
﹤0.01% 334
2022
Q1
$6K Hold
23,333
﹤0.01% 376
2021
Q4
$18K Hold
23,333
﹤0.01% 311
2021
Q3
$15K Buy
+23,333
New +$19K ﹤0.01% 378

Other funds holding COCHW

OMERS Administration Corp's COCHW Position: Q1 2026 in Review

OMERS Administration Corp held its Envoy Medical Warrant (COCHW) position steady in Q1 2026 at 23,333 shares worth $1.55K. The position accounts for ﹤0.01% of the portfolio, ranked #1084.

OMERS Administration Corp first reported a position in COCHW in Q3 2021 and has held it in 19 quarters since. The position peaked at $18K in Q4 2021. 34 funds tracked by Wall St. Rank hold COCHW as of Q1 2026.

  • OMERS Administration Corp held 23,333 shares of Envoy Medical Warrant worth $1.55K as of Q1 2026.
  • OMERS Administration Corp left its Envoy Medical Warrant share count unchanged in Q1 2026.
  • Envoy Medical Warrant made up ﹤0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #1084 holding.
  • OMERS Administration Corp first reported a position in Envoy Medical Warrant in Q3 2021 and has held it in 19 quarters since.
  • OMERS Administration Corp's Envoy Medical Warrant position peaked at $18K in Q4 2021.
  • 34 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.